Breathe Well Live Well
|
Treatment of allergic asthma: Modulation of Th2 cells and their responses
7thSpace Interactive (press release) Atopic asthma is a chronic inflammatory pulmonary disease characterised by recurrent episodes of wheezy, laboured breathing with an underlying Th2 cell-mediated inflammatory response in the airways. It is currently treated and, more or less, … |
View full post on asthma – Google News
|
2 Responses to “New asthma research breaks the mold”
ScienceBlog.com (blog) There are many physicians that have been reporting patients having symptoms similar to asthma after exposure to molds and bacteria found in water damaged … |
View full post on asthma – Google News
Conditions: Asthma; Cough Variant Asthma
Interventions: Drug: high-dose methacholine challenge test; Other: mannitol challenge test
Sponsor: Queen’s University
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
A new nationwide research initiative has been launched to define changes in the human immune system, using human and not animal studies, in response to infection or to vaccination. Six U. S.-based Human Immune Phenotyping Centers will receive a total of $100 million over five years to conduct this research.
View full post on National Institutes of Health (NIH) News Releases